Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials

BACKGROUND: Mycoplasma pneumoniae is one of the most common pathogens causing community acquired pneumonia in children. Although the rate of macrolide-refractory Mycoplasma pneumoniae (MRMP) has increased, systemic glucocorticoids as a treatment option has not been validated yet. The purpose of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hwan Soo, Sol, In Suk, Li, Donghe, Choi, Miyoung, Choi, Yun Jung, Lee, Kyung Suk, Seo, Ju Hee, Lee, Yong Ju, Yang, Hyeon-Jong, Kim, Hyun Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921474/
https://www.ncbi.nlm.nih.gov/pubmed/31852460
http://dx.doi.org/10.1186/s12890-019-0990-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921474/
https://www.ncbi.nlm.nih.gov/pubmed/31852460
http://dx.doi.org/10.1186/s12890-019-0990-8

Ejemplares similares